{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:14:34Z","timestamp":1765901674407,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"DOI":"10.7759\/cureus.99381","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T15:55:35Z","timestamp":1765900535000},"source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Analysis of Extended-Spectrum \u03b2-Lactamase (ESBL)-Producing Enterobacterales Bacteremia in Tertiary Care Hospitals in the United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Ali","family":"Al Hassani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aqeel","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Al Hassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Shubbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdilsalhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Al Naqbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifa","family":"Al Kamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujein","family":"Watad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merna","family":"Abdelsalhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Al Hassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al Hammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/625170","article-title":"ESBLs: a clear and present danger?","volume":"2012","author":"Dhillon RH","year":"2012","unstructured":"Dhillon RH, Clark J. ESBLs: a clear and present danger?. Crit Care Res Pract. 2012, 2012:625170. 10.1155\/2012\/625170","journal-title":"Crit Care Res Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2007.08.003","article-title":"The continuing challenge of ESBLs","volume":"7","author":"Perez F","year":"2007","unstructured":"Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol. 2007, 7:459-69. 10.1016\/j.coph.2007.08.003","journal-title":"Curr Opin Pharmacol"},{"key":"ref3","unstructured":"Antimicrobial resistance threats in the United States. (2022). Accessed. 10\/08\/2025: https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html."},{"key":"ref4","unstructured":"COVID-19 U.S. impact on antimicrobial resistance. (2022). Accessed. 10\/08\/2025: https:\/\/www.cdc.gov\/antimicrobial-resistance\/media\/pdfs\/covid19-impact-report-508.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112937","article-title":"Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities","volume":"11","author":"Husna A","year":"2023","unstructured":"Husna A, Rahman MM, Badruzzaman AT, et al.. Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities. Biomedicines. 2023, 11:5-7. 10.3390\/biomedicines11112937","journal-title":"Biomedicines"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03361-13","article-title":"Modified CLSI extended-spectrum \u03b2-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various \u03b2-lactamases","volume":"52","author":"Poulou A","year":"2014","unstructured":"Poulou A, Grivakou E, Vrioni G, Koumaki V, Pittaras T, Pournaras S, Tsakris A. Modified CLSI extended-spectrum \u03b2-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various \u03b2-lactamases. J Clin Microbiol. 2014, 52:1483-9. 10.1128\/JCM.03361-13","journal-title":"J Clin Microbiol"},{"key":"ref7","unstructured":"CDC\/NHSN surveillance definitions for specific types of infections. (2025). Accessed. 10\/08\/2025: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","unstructured":"Global burden of bacterial antimicrobial resistance in 2019. a systematic analysis. Lancet. 2022, 399:629-55. 10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"ref9","unstructured":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual Epidemiological Report for 2019. (2020). Accessed. 10\/08\/2025: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2019."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"4","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. 2024, 4:18-9. 10.1093\/cid\/ciae403","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/00010958710.1159\/000109587","article-title":"Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-Producing enterobacteriaceae in the United Arab Emirates","volume":"6","author":"Al-Zarouni M","year":"2007","unstructured":"Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-Producing enterobacteriaceae in the United Arab Emirates. Med Princ Pract. 2007, 6:32-6. 10.1159\/00010958710.1159\/000109587","journal-title":"Med Princ Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1244482","article-title":"Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021","volume":"11","author":"Thomsen J","year":"2023","unstructured":"Thomsen J, Abdulrazzaq NM, Everett DB, Menezes GA, Senok A, Ayoub Moubareck C. Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021. Front Public Health. 2023, 11:1244482. 10.3389\/fpubh.2023.1244482","journal-title":"Front Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2023.01.005","article-title":"Retrospective analysis of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacterales: the challenge of healthcare-associated infections","volume":"6","author":"Peri AM","year":"2023","unstructured":"Peri AM, Calabretta D, Bozzi G, Migliorino GM, Bramati S, Gori A, Bandera A. Retrospective analysis of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacterales: the challenge of healthcare-associated infections. IJID Reg. 2023, 6:167-70. 10.1016\/j.ijregi.2023.01.005","journal-title":"IJID Reg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"45","author":"Thomson KS","year":"2001","unstructured":"Thomson KS, Moland ES. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2001, 45:3548-54. 10.1128\/AAC.45.12.3548-3554.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz226","article-title":"Inoculum effect of \u03b2-lactam antibiotics","volume":"74","author":"Lenhard JR","year":"2019","unstructured":"Lenhard JR, Bulman ZP. Inoculum effect of \u03b2-lactam antibiotics. J Antimicrob Chemother. 2019, 74:2825-43. 10.1093\/jac\/dkz226","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11233048","article-title":"Improving antimicrobial stewardship program using the Lean Six Sigma methodology: a descriptive study from Mediclinic Welcare Hospital in Dubai, the UAE","volume":"11","author":"Sallam M","year":"2023","unstructured":"Sallam M, Snygg J. Improving antimicrobial stewardship program using the Lean Six Sigma methodology: a descriptive study from Mediclinic Welcare Hospital in Dubai, the UAE. Healthcare (Basel). 2023, 11:6-8. 10.3390\/healthcare11233048","journal-title":"Healthcare (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or K. pneumoniae bloodstream infection and ceftriaxone resistance (MERINO): a randomized clinical trial","volume":"320","author":"Harris PN","year":"2018","unstructured":"Harris PN, Tambyah PA, Lye DC, et al.. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or K. pneumoniae bloodstream infection and ceftriaxone resistance (MERINO): a randomized clinical trial. JAMA. 2018, 320:984-94. 10.1001\/jama.2018.12163","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"Tumbarello M","year":"2007","unstructured":"Tumbarello M, Sanguinetti M, Montuori E, et al.. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007, 51:1987-94. 10.1128\/AAC.01509-06","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami R","year":"2009","unstructured":"Ben-Ami R, Rodr\u00edguez-Ba\u00f1o J, Arslan H, et al.. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009, 49:682-90. 10.1086\/604713","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11020074","article-title":"Risk factors for bloodstream infections due to ESBL-producing Escherichia coli, Klebsiella spp., and Proteus mirabilis","volume":"11","author":"Vance MK","year":"2023","unstructured":"Vance MK, Cretella DA, Ward LM, Vijayvargiya P, Garrigos ZE, Wingler MJ. Risk factors for bloodstream infections due to ESBL-producing Escherichia coli, Klebsiella spp., and Proteus mirabilis. Pharmacy (Basel). 2023, 11:8-9. 10.3390\/pharmacy11020074","journal-title":"Pharmacy (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406169-a-retrospective-analysis-of-extended-spectrum--lactamase-esbl-producing-enterobacterales-bacteremia-in-tertiary-care-hospitals-in-the-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T15:55:36Z","timestamp":1765900536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406169-a-retrospective-analysis-of-extended-spectrum--lactamase-esbl-producing-enterobacterales-bacteremia-in-tertiary-care-hospitals-in-the-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.99381","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,16]]}}}